Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14657
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2018
Authors
Publisher
Wiley